Research confirms benefits of side-actuated nasal spray

Published: 8-Feb-2010
Ingredients Drug Delivery Research & Development Pharmaceutical

Valois Pharma's side-actuated nasal spray has excellent ergonomics, is comfortable to handle and easy to actuate, research by the French pharmaceutical company reveals.

Valois Pharma's side-actuated nasal spray has excellent ergonomics, is comfortable to handle and easy to actuate, research by the French pharmaceutical company reveals.

The side-actuated nasal spray consists of a standard actuator coupled with a customisable shell and cap.

The research, carried out in the UK last November involving 10 regular nasal spray users, as well as six doctors (GPs and ENT specialists), showed that the side-actuated delivery device has the three advantages mentioned above.

Patients also thought a slightly longer nozzle would improve the placement of the device in the nostril when the device is actuated, and Valois will further investigate this.

The company says new user research will be carried out in the US in the coming months to confirm the results of the current study.




See more

You may also like

Manufacturing

Gerresheimer adjusts 2025 guidance amid slower market growth

Read more
Transformation program launched to boost performance and free cash flow

Trending Articles

  1. SPT Labtech and Agilent introduce automated target enrichment protocols for genomic workflows Automating genomic workflows, the optimised Target Enrichment protocols support researchers using Agilent’s SureSelect Max DNA Library Prep kits
  2. New Ultrapyc 7000 series expands Anton Paar’s gas pycnometer lineup Two new models deliver high throughput and precision for small sample measurements
  3. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
  4. Intertronics releases white paper on process validation for medical device bonding The new guidance helps manufacturers cut costs, save time and ensure ISO and FDA compliance by designing out variability and improving process reliability from the start
  5. FDA lifts clinical hold on Neurizon’s NUZ-001 for ALS trial entry The decision clears the path for NUZ-001 to join the HEALEY ALS Platform Trial later this year, advancing Neurizon’s lead therapy for amyotrophic lateral sclerosis and strengthening its regulatory and development pipeline

Upcoming event

CPHI Frankfurt 2025

28–30 October 2025 | Exhibition | Frankfurt, Germany See all

You may also like

Manufacturing

Gerresheimer adjusts 2025 guidance amid slower market growth

Transformation program launched to boost performance and free cash flow
Pharmaceutical

ProSpecBio launches CHO cell-derived Activin-A recombinant protein to advance inflammation and brain injury research

ProSpecBio has introduced a highly purified, CHO cell-derived recombinant Activin-A protein, enabling researchers worldwide to explore its therapeutic potential in inflammation, brain injury and regenerative medicine
Pharmaceutical

Asahi Kasei expands Sonanos portfolio with next-generation excipients for injectable drug formulation

Asahi Kasei has introduced two new speciality grades in its Sonanos excipient line designed to enhance sustained release and solubility in injectable drugs and plans GMP-compliant production by 2027
Manufacturing

New Ultrapyc 7000 series expands Anton Paar’s gas pycnometer lineup

Two new models deliver high throughput and precision for small sample measurements
Research & Development

Pharma leaders must separate AI hype from actionable opportunity, warns NIRAS

A new report from the company urges pharmaceutical executives to approach AI adoption with trust, transparency and traceability, outlining how the technology can drive compliance and productivity whilst warning against risks from poor data quality and opaque models
Media

Celerion earns five-year AAHRPP reaccreditation, reinforcing leadership in ethical clinical research

Celerion becomes the only US-headquartered CRO to hold the distinction, underscoring its long-standing commitment to participant safety and research integrity
Research & Development

UK and Japan biotech associations sign MoU to strengthen life sciences collaboration

The UK BioIndustry Association and Japan Bioindustry Association have signed a Memorandum of Understanding to connect the two nations’ biotech ecosystems, promoting joint innovation, trade and the development of new biotechnologies
Subscribe now